FIELD: chemistry of peptides, medicine, pharmacy. SUBSTANCE: linear or cyclic peptide of the general formula: D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 or its derivative or its salt is used for production of drug designated for treatment and prophylaxis of patients with intestine inflammatory diseases. Method involves administration to patient an effective amount of peptide - from 0.05 to 1000 mg peptide per a day. Peptide is administrated as a pharmaceutical composition in combination with pharmaceutically acceptable carrier. Pharmaceutically acceptable carriers are taken from carriers that make a composition to be suitable for intranasal administration, for oral, buccal, parenteral, local or rectal route of administration or by inhalation. EFFECT: enhanced effectiveness of patient treatment. 13 cl, 17 dwg, 14 tbl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS USED FOR ASSESSING CYTOTOXICITY OF SINGLE CELLS | 2009 |
|
RU2532228C2 |
STEM CELL PROLIFERATION INHIBITOR AND STIMULANT AND USAGE THEREOF | 1997 |
|
RU2292352C9 |
METHODS FOR IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH 4-1BB AGONIST | 2019 |
|
RU2788524C2 |
METHODS OF EXPANSION OF ANTIGEN-SPECIFIC CAR-T-CELLS, COMPOSITIONS AND THEIR USE | 2019 |
|
RU2800920C2 |
COMBINATION THERAPY WITH SEMAFORIN 4D (SEMA4D) BLOCKING AND DC1 THERAPY | 2020 |
|
RU2801828C2 |
BISPECIFIC MOLECULES, IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS EXPRESSING AN ACTIVATING RECEPTOR | 2014 |
|
RU2721707C2 |
DRUGS FOR TREATING DISEASES | 2010 |
|
RU2598719C2 |
CHAPERONIN 10 MODULATION OF TOLL-LIKE RECEPTOR INDUCIBLE CYTOKINE AND CHEMOKINE SECRETION | 2005 |
|
RU2446817C2 |
NOVEL ANTI-PD-L1 ANTIBODIES | 2016 |
|
RU2736151C2 |
TREATMENT AND FUNCTIONAL CURE OF HIV-INFECTION WITH MONOCLONAL ANTIBODIES TO CD4 MEDIATING COMPETITIVE INHIBITION OF HIV ENTRY | 2014 |
|
RU2762315C2 |
Authors
Dates
1999-05-20—Published
1993-03-29—Filed